GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (LSE:CNSL) » Definitions » Research & Development

Cambridge Nutritional Sciences (LSE:CNSL) Research & Development : £0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cambridge Nutritional Sciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Cambridge Nutritional Sciences's Research & Development for the six months ended in Sep. 2024 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was £0.00 Mil.

Cambridge Nutritional Sciences Research & Development Historical Data

The historical data trend for Cambridge Nutritional Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambridge Nutritional Sciences Research & Development Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cambridge Nutritional Sciences Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cambridge Nutritional Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cambridge Nutritional Sciences  (LSE:CNSL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cambridge Nutritional Sciences Research & Development Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Cambridge Nutritional Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (LSE:CNSL) » Definitions » Research & Development
Comparable Companies
LSE:RUA LSE:MHC LSE:SUN LSE:BELL LSE:POLX LSE:IHC ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN
Traded in Other Exchanges
N/A
Address
One Fleet Place, London, GBR, EC4M 7WS
Website
https://www.cnsplc.com
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis to the general public, clinics, and health professionals as well as supplying the point-of-care Food Detective test. The Corporate segment consists of centralised corporate costs which are not allocated to the trading activities of the group. The company generates the majority of its revenue from the Health and Nutrition segment.